← Back to Search

eHealth for Covid-19 prevention and support for Coronavirus (COVID-19 Trial)

N/A
Waitlist Available
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline survey, 2-week post-intervention survey, and 2-month post-intervention survey
Awards & highlights

COVID-19 Trial Summary

#SafeHandsSafeHearts: An eHealth Intervention for COVID-19 Prevention and Support

Eligible Conditions
  • Coronavirus

COVID-19 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline survey, 2-week post-intervention survey, and 2-month post-intervention survey
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline survey, 2-week post-intervention survey, and 2-month post-intervention survey for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in COVID-19 knowledge
Change in COVID-19 protective behaviors
Change in anxiety symptoms
+1 more
Secondary outcome measures
Change in loneliness/social isolation

COVID-19 Trial Design

2Treatment groups
Experimental Treatment
Group I: WaitlistExperimental Treatment1 Intervention
Behavioral: Motivational interviewing (MI)-based peer counseling: After the immediate group completes the intervention, the waitlist group will receive the intervention. MI-based peer counseling will comprise of 3 weekly 1-hour sessions administered online addressing 1) Covid-19 knowledge; 2) Assessing risk for infection and understanding and practicing public health-recommended protective behaviors (masking, physical distancing, handwashing); and 3) Understanding psychosocial issues and maintaining mental wellness.
Group II: ImmediateExperimental Treatment1 Intervention
Behavioral: Motivational interviewing (MI)-based peer counseling: MI-based peer counseling will comprise of 3 weekly 1-hour sessions administered online addressing 1) Covid-19 knowledge; 2) Assessing risk for infection and understanding and practicing public health-recommended protective behaviors (masking, physical distancing, handwashing); and 3) Understanding psychosocial issues and maintaining mental wellness.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
eHealth for Covid-19 prevention and support
2021
N/A
~860

Find a Location

Who is running the clinical trial?

University of TorontoLead Sponsor
689 Previous Clinical Trials
1,017,790 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
#SafeHandsSafeHearts: An eHealth Intervention for COVID-19 Prevention and Support
Peter A. Newman 2021. "#SafeHandsSafeHearts: An eHealth Intervention for COVID-19 Prevention and Support". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04870723.
~209 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top